Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.

Targeted Treatment against Cancer Stem Cells in Colorectal Cancer

Open access
Martínez-Pérez, Julia, Torrado, Carlos, Domínguez-Cejudo, María A., Valladares-Ayerbes, Manuel · 2024 · International Journal of Molecular Sciences

Abstract

The cancer stem cell (SC) theory proposes that a population of SCs serves as the driving force behind fundamental tumor processes, including metastasis, recurrence, and resistance to therapy. The standard of care for patients with stage III and high-risk stage II colorectal cancer (CRC) includes surgery and adjuvant chemotherapy. Fluoropyrimidines and their combination with oxaliplatin increased the cure rates, being able to eradicate the occult metastatic SC in a fraction of patients. The treatment for unresectable metastatic CRC is based on chemotherapy, antibodies to VEGF and EGFR, and tyrosine-kinase inhibitors. Immunotherapy is used in MSI-H tumors. Currently used drugs target dividing cells and, while often effective at debulking tumor mass, these agents have largely failed to cure metastatic disease. SCs are generated either due to genetic and epigenetic alterations in stem/progenitor cells or to the dedifferentiation of somatic cells where diverse signaling pathways such as Wnt/β-catenin, Hedgehog, Notch, TGF-β/SMAD, PI3K/Akt/mTOR, NF-κB, JAK/STAT, DNA damage response, and Hippo-YAP play a key role. Anti-neoplastic treatments could be improved by elimination of SCs, becoming an attractive target for the design of novel agents. Here, we present a review of clinical trials assessing the efficacy of targeted treatment focusing on these pathways in CRC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms25116220

Cites

131 of 132 references verified0 citation errors · 1 not checkable

Statistics

Figures

Figure 1 Signaling Pathways and Their Roles in Colorectal Cancer Stem cell (CRC-SC) hallmarks. These pathways collectively contribute to the intricate regulatory network that supports the malignancy and plasticity of CSCs and highlights potential therapeutic targets.
Figure 1 Signaling Pathways and Their Roles in Colorectal Cancer Stem cell (CRC-SC) hallmarks. These pathways collectively contribute to the intricate regulatory network that supports the malignancy and plasticity of CSCs and highlights potential therapeutic targets.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 132 references

Cited by

See all 18

Metadata

Authors
Martínez-Pérez, J., Torrado, C., Domínguez-Cejudo, M. A., & Valladares-Ayerbes, M.
Affiliations
  • Medical Oncology Department, Hospital Universitario Virgen del Rocio (HUVR), Avenida de Manuel Siurot s/n, 41013 Seville, Spain
  • The University of Texas MD Anderson Cancer Center (US)
  • Institute of Biomedicine of Seville (IBiS), Hospital Universitario Virgen del Rocio (HUVR), Consejo Superior de Investigaciones Científicas, Universidad de Sevilla, Avenida de Manuel Siurot s/n, 41013 Seville, Spain
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2024-06-05
Volume
25
Issue
11
Pages
6220
ISSN
1422-0067 (ISSN-L)
OpenAlex
W4399366851
Cited by
18
References
132
Citations by year
2026: 3 · 2025: 7 · 2024: 8
FWCI
0.96
Type
journal article
Language
en
Open access
Locations
  • International Journal of Molecular Sciences (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion, other-oa)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
Keywords
colorectal cancer, cancer stem cells, targeted therapy, metastatic colorectal cancer, adjuvant chemotherapy, fluoropyrimidine, oxaliplatin, VEGF inhibitors, EGFR inhibitors, tyrosine kinase inhibitors, immunotherapy, microsatellite instability-high, Wnt/β-catenin signaling, Hedgehog signaling, Notch signaling, TGF-β/Smad signaling, PI3K/AKT/mTOR pathway, NF-κB signaling, JAK/STAT signaling, DNA damage response, Hippo/YAP signaling, dedifferentiation, clinical trials
MeSH terms
Animals, Antineoplastic Agents, Humans, Neoplastic Stem Cells, Colorectal Neoplasms, Signal Transduction, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeted Treatment against Cancer Stem Cells in Colorectal Cancer. https://app.cochat.ai/papers/10.3390/ijms25116220
The paper
Martínez-Pérez, J., Torrado, C., Domínguez-Cejudo, M. A., & Valladares-Ayerbes, M. (2024). Targeted Treatment against Cancer Stem Cells in Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25116220

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.